The existence of an ecto-sialyltransferase (ecto-ST) on B lymphocytes with increasing activity at late maturation stages is shown using a novel flow cytometric enzyme assay. This ecto-ST is effective in reconstituting different surface glycoconjugates on desialylated B cells in the presence of exogenous CMP-NeuAc. We found that this ecto-ST is distinct in its activity from soluble ST released into the culture supernatant. Surface sialylation was independent of the amount of ST secreted into the culture supernatant and followed different kinetics than sialylation of exogenous substrate by soluble ST. Four human B-cell lines representing different maturation stages were analyzed for secreted and ecto-ST activity. The myeloma cell line U266 and the lymphoblastoid cell line JOK-l showed higher activity of both STforms than the acute lymphoblastic leukemia B-cell line Nalm-6. ST activity in culture supernatants of U266, JOK-l, and Nalm-6 cells consisted predominantly of the a2.6 STtype with specificity for N-linked oligosaccharides. As an exception, the myeloma cell line IM-9, deficient of a2.6 ST activity, secreted only small amounts of ST and showed low activity of ecto-ST. Sialylation of surface-expressed glycoconjugates by ecto-ST was measured by incubating B-cell lines in the pres-
S
ence of fluorescent CMP-sialic acid. Surface structures labeled with fluorescent sialic acid under this condition were visualized by confocal laser scanning microscopy and fluorescent label was quantitatively assessed by flow cytometric analysis on live cells. Incubation of cells in acidified culture medium, t o release possibly receptor-bound ST, did not alter the intensity of cell surface sialylation. Inhibition of internalization and membrane traffic by various approaches (reduced incubation temperature and chloroquine or brefeldin A treatment) did not block surface sialylation. Together, these observations point t o cell surface sialylation in B lymphocytes mediated by a cell surface-expressed ecto-ST distinct from the secreted ST form. On desialylated JOK-l cells, ecto-ST in the presence of exogenous CMP-NeuAc was able t o resialylate the B-cell surface sialoglycans CDw75 and HB-6 and major surface glycoproteins of B cells, such as HLA class I and II antigens, transferrin receptor, and surface IgM. In contrast, cell surface glycans of coincubated desialylated erythrocytes were not sialylated by the B-cell ecto-ST. Ectoa2. 6 ST of B cells may be involved in the sialylation of distinct differentiation glycan antigens. 0 1996 by The American Society of Hematology.
Glycosyltransferases are integral membrane proteins of the Golgi apparatus." Also, soluble forms of glycosyltransferases have been identified in several body fluids." For instance, increased ST activity has been reported in sera of patients during inflammation and tumor gro~th.'~,'' These soluble enzymes seem to originate from membrane-bound forms released by proteolytic cleavage of the NH2-terminal signal anchor.*' In earlier studies, murine B lymph~ma?~ melanoma cells,% rat hepatoma cells:
and chicken neur o d 6 have been reported to produce extracellular ST activity that is able to sialylate cell surface structures. The presence of ST at the plasma membrane has been indicated by immunoelectron microscopy st~dies.'~~'~ The question whether ST exist as cell surface-associated molecule, possibly derived from secreted material, or as a distinct membrane-integrated enzyme was still a matter of debate.
Evidence has been provided for the existence of a cell For the surface-expressed galactosyltransferase, a
MATERIALS AND METHODS

Materials
All chemicals used were of analytical grade and purchased from Merck (Darmstadt, Germany) or Serva (Heidelberg, Germany). Nylon membranes (Immobilon-P) were from Millipore (Bedford, MA). Bio-Rad adhesion slides were from Bio-Rad (Munich, Germany). 2,3-Dehydro-NeuAc, vibrio cholerae neuraminidase (VCN; EC 3.2.1.18), a2,6ST (GalP1,4GlcNAc-(u2,6ST, EC 2.4.99.1, from rat liver), a2,3ST (Galpl,3GalNAccr2,3 ST, EC 2.4.9.94 from porcine liver), digoxigenin-labeled lectins Maackia amurensis agglutinin (MAA) and Sambucus nigra agglutinin (SNA), fetuin, and transfemn were obtained from Boehringer Mannheim (Mannheim, Germany). Cytidine S'-triphosphate (CTP) was obtained from Biomol (Ilvesheim, Germany). Bovine serum albumin (radioimmunoassay [RIA] grade), a,-acid glycoprotein, asialo-mucin, propidium iodide, brefeldin A, chloroquine, alkaline phosphatase substrates nitro-blue tetrazolium (NBT) and 5-bromo-4-chloro-3'-indolylphosphate p-toluidine salt (BCIP), trypsin (EC 3.4.21.4), and Triton X-100 were from Sigma (St Louis, MO). CMP-NeuAc, CMP-9-F-NeuAc (cytidine-5'-monophospho-9-fluoresceinylthioureido-5-N-acetyl-neura~nic-acid), CMP-5-F-Neu (cytidine-5'-monophospho-5-N-fluoresceinylthioureidoacetyl-neu raminic acid), and CMP-9-AMCA-NeuAc were prepared enzymatically (CMP contamination in each preparation 4 % ) . as described p r e v i o~s l y .~~.~~ Sephadex G50 fine was From Pharmacia (Uppsala, Sweden). Desialylation of glycoproteins was performed by acid hydrolysis as de~cribed.'~ Cell lines. For this study, we chose four different B-cell lines that originate from B-cell malignancies affiliated to early and late stages of normal B-cell ~ntogeny.'~.~' The pre-B-cell line Nalm-6 was originally derived from bone marrow of a patient with acute lymphocytic leukemia:" cell line JOK-1 from peripheral blood of a patient with hairy cell leukemia:' cell line U266 from peripheral blood of a patient with an IgE myeloma,4* and cell line IM-9 from bone marrow of a patient with a multiple myeloma.43 All cell lines were maintained in RPM1 1640 supplemented with S 6 fetal calf serum. For determination of endogenous, ecto-ST activities, cells were cultivated for 48 hours in serum free PFHM 11 medium (GIBCO, Eggenstein, Germany) before the tests.
Cell line Nalm-6 carries markers of early B-cell maturation (CDIO, CD19, CD24, and CD72). JOK-l cells express markers of activated B cells (CD21, CD22, and CDw75). Cell line U266 is deficient for almost all known B-cell differentiation markers except for CD44, CD73, and CDw75, which characterizes late stages of B-cell acti~ation.~~~'' Similarily, cell line IN-9 expresses only few B-cell differentiation markers with either a broad presence during maturation reaching to the blast stage (CD39 and CD78) or with pronounced presence on activated B cells (CD23).
Antibodies. The CDw76 MoAb HD66 was produced in our laboratory.x MoAb CRIS 4 of CDw76 was kindly donated by Dr R. Villela (Barcelona, Spain). The CDw75 MoAb HH2 was a generous gift of Dr S. Fundenrd (The Norwegian Radium Hospital, Oslo, Norway). Antibodies HB-4 and HB-6 and MoAb VIB-E3 of the CD24 panel were obtained from the Fourth International Workshop On Human Leucocyte Differentiation Antigens. The MoAb lB244 was produced using the respective hybridoma 1B2-1B7 obtained from the American Tissue Culture Collection (Rockville, MD). All MoAbs against carbohydrate epitopes used here are of IgM isotype.
For immunoprecipitation studies, we used MoAb W6/32 against the human HLA class I molecule,4s MoAb L243 against HLA class
MoAb PA-l against the transferrin receptor (CD71),'X and MoAb NMZ88.5 against the p Ig A mouse anti-fluorescein isothiocyanate (FITC) MoAb was purchased from Serotech (Wiesbaden, Germany).
The following second immune reagents were used: goat antimouse IgG + IgM (Fab), conjugated to FITC (Dianova, Hamburg, Germany) and sheep anti-FITC (Fah) coupled to alkaline phosphatase (Boehringer Mannheim).
Methods
Fluorometric ST assay. For determination of secreted ST, I X lo7 cells/mL were incubated in phosphate-buffered saline (PBS), pH 7.5, at 37°C for the times indicated. Culture supernatants were centrifuged at SOOg to remove residual cells; the supernatant of a subsequent centrifugation at 10,000g for 15 minutes was taken for determination of ST activity. The following glycoproteins were used as acceptors: 3 mg/mL asialofetuin, I .6 m g h L asialo-a,-acid glycoprotein, and 3 mglmL asialomucin. The assay was performed using CMP-9-F-NeuAc; the reaction mixture, containing 10 pL of the conditioned supematant, was incubated for 1 hour at 37°C:" Corresponding controls were run in the presence of 12 m m o E CTP. The assay followed a linear time course for at least 2 hours and was linear with enzyme amount up to 15 pL of ST containing supernatant. Donor substrate concentration approximated saturation (3-fold KM value; see Fig S) . The fluorescence incorporated into glycoprotein acceptors was determined using the liquid chromatography system developed prev i o~s l y .~~ Samples (5 to 20 pL) were analyzed by chromatography on Sephadex G50 fine run with 0.1 moln Tris, pH 8.6, 80 mmol/ L NaC1, and 0.2% (vol/vol) Nonidet P-40 at 1 W m i n . ST activity was calculated in comparison with an external CMP-9-F-NeuAc standard.
For determination of glycosidic linkage specificity of ST, a novel, sensitive fluorometric assay was used. The reaction mixture (20 p L volume) was composed as follows: 0.25 mo1L sodium cacodylate, pH 6 5 , 125 mmol/L lactose, 50 p m o K CMP-9-AMCA-NeuAc,
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and 5 to 10 pL of sample. The reaction mixture was incubated for 2 hours at 37°C; corresponding controls contained 12 mmol/L CTP. The linearity of the enzyme assay with incubation time and amount of ST was as indicated above. The amount of lactose isomers sialylated in a2,6-or a2,3-linkage by the respective ST with 9-AMCANeuAc as substrate was determined by a fluorometric high-performance liquid chromatography (HPLC) system based on the system described p r e v i o~s l y .~~.~~ Isomers were separated on an aminopropylphase column (25 X 0.4 cm) run isocratically with 15 mmoVL KH,POdacetonitrile (25/75, vol/vol) at 4 &min. The column effluent was monitored using an Hitachi F-1000 spectrofluorometer (excitation 345 nm, emission 445 nm; Merck, Darmstadt, Germany). The fluorescent lactose isomers sialylated in a2,3-or a2.6-linkage were identified and quantified with respect to corresponding external standards that were prepared using the assay described above with commercially available a2,6-ST and a2,3-ST (Boehringer Mannheim) as the enzyme source. The retention time for the a2,3 isomer was 6.6 minutes and that of the a2,6 isomer was 8.7 minutes.
Flow cytometric detection of cell surface sialylation. For cytometric detection of surface sialylation by endogenous, extracellular ST and exogenous ST of rat liver, cells were preincubated in serumfree medium (PFHM 11) for 48 hours. We found that fetal calf serum used for cell culture contains ST activity (approximately 2 pU/mL) that may accumulate at the cell surface. Although the influence of serum ST was minor and only clearly visible in cells with constitutively low ST activity such as I"9 and Nalm-6, we preferred shortterm culture in serum-free medium before the test to avoid background activity of serum ST. Culture of cells in serum-free medium neither changed viability nor proliferative activity compared with cells cultivated in medium with 5% fetal calf serum.
The cells were washed with PBS and then either treated with or without VCN (5 mU/1 X lo6 cells/100 pL PBS) for 30 minutes at 37°C. Cells (1 X 106/100 pL PBS) were incubated for times indicated at 37°C with the addition of either CMP-5-F-Neu or CMP-9-FNeuAc at 25 pmoUL, representing the approximate saturating concentration (3-fold KM value). In some experiments, exogenous a2,6 ST of rat liver was added at concentrations of 0.1 mU/lOO pL and 1 mU/IOO pL. In previous experiments, it was found that, during an incubation time of 120 minutes, viability of cells was greater than 95% regardless of whether PBS or RPMI 1640 medium was used as the incubation medium. We always used PBS as the incubation medium. For cytometric analysis using a FACScan cytometer (Becton Dickenson, Mountain View, CA), cells were washed twice and the cell pellet resuspended in RPMI 1640 medium containing 1 pg/mL propidium iodide. Green fluorescence of 1 X lo4 viable cells was analyzed by excluding dead cells identified by red fluorescence (propidium iodide label). For kinetic experiments, fluorescence intensity was determined as the mean fluorescence of fluorescent NeuAc per stained cell, calculated by the Lysis I1 software program (Becton Dickenson). As background values, we used the fluorescence of cells incubated at 0°C with fluorescent CMP-glycosides or incubated at 37°C in the additional presence of CTP (2 mmoVL).
Possible effects of intracellular recycling of membrane glycans on surface sialylation were examined by blocking internalization at a reduced incubation temperature. First, JOK-1 cells were desialylated by treatment with VCN (50 mU/mL) for 2 hours at 8°C. VCN was removed by washing the cells and the cells were subsequently incubated for 3 hours at 8°C in the presence of CMP-5-F-Neu, as outlined above. Corresponding controls additionally contained 2 mmoVL CTP. Aliquots were harvested after appropiate times and surface fluorescence labeling was measured by flow cytometry as described above.
Also, JOK-1 cells were fixed in various concentrations of glutaraldehyde (O.Ol%, 0.02%, and 0.05%) for 1 minutes on ice, quenched in 0.2 m o m glycine for 5 minutes on ice, and washed three times in PBS before application in the cytometric sialylation assay as described above.
To further investigate involvement of membrane trafficking in surface sialylation, we treated desialylated JOK-l cells with various doses of chloroquine (20, 50, and 100 pmoVL) for 45 minutes at 37°C. Sialylation of intact cells in the presence of CMP-5-F-Neu and chloroquine in the respective concentrations was performed at 37°C for 1 hour. Surface fluorescence labeling was measured by flow cytometry. Desialylated JOK-I cells were also treated with brefeldin A at various concentrations (2, 5, and 10 pmol/L) for 45 minutes at 37°C. Cell surface sialylation as described above was performed in the presence of brefeldin A in the respective concentrations.
To determine whether cell surface-located ST is able to sialylate carbohydrate structures on other adjacent cells, human erythrocytes (Sangocell S; Behring Werke, Marburg, Germany) desialylated by VCN were cocultivated with JOK-l cells. Label transfer was assayed as follows. JOK-l cells (1 X lo6 cells/mL) and desialylated erythrocytes (5 x IO5 cells/mL) were cultivated in the presence of 25 pmoVL CMP-5-F-Neu for up to 20 hours at 8°C. The fluorescence transferred to the cell surfaces was determined by flow cytometry using different instrument settings and electronic gates (JOK-1 cells: FSClSSC linear mode; erythrocytes: FSCISSC logarithmic mode).
Resialylation of dejined sur$ace antigens and glycan structures. To monitor the capacity of ecto-ST to resialylate MoAb-defined surface structures, we incubated VCN-treated JOK-1 cells together with 25 pmol/L CMP-5-F-Neu for 2 hours at 37°C. Cells were washed and lysed for 15 minutes at 0°C in lysis buffer that consisted of PBS containing 1% Triton X-100 and 1 m m o n each of phenylmethylsulfonyl fluoride (PMSF), N-ethylmaleimide (NEM), and aprotinin. The cell lysate was centrifuged in an Eppendorf centrifuge for 15 minutes at 0°C. The supernatant was then taken for unspecific absorption of cellular proteins and specific immunoprecipitation as described p r e v i o~s l y .~~ Immunoprecipitates were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and subsequent Western blotting. Western-blotted proteins were incubated overnight at 4°C in PBS containing 3% bovine serum albumin (BSA). Incubation with sheep anti-FITC IgG (Fab-fragment) coupled to alkaline phosphatase diluted 1: 1,000 in PBS containing 1% BSA was performed for 1 hour at room temperature. Immune reaction was visualized by using substrates NBT and BCIP.
Resialylation of glycan structures by ecto ST was examined by using MoAb against defined a2,6 sialylated glycan epitopes. For this, VCN-treated or untreated JOK-l cells were incubated in the presence of 400 pmoVL CMP-NeuAc for 2 hours at 37°C. In some experiments, rat liver a2,6 ST was added (8 mU/200 pL) for the same incubation time. For each step of the experiment (ie, untreated cells, VCN-treated cells, and resialylated cells with and without addition of exogenous ST), indirect immunofluorescence of MoAblabeled cells was measured by flow cytometry.
Confocal laser scanning microscopy. For detection of surface sialylation at the microscopic level, 5 X lo4 cells/reaction field were applied to Bio-Rad adhesion slides (Bio-Rad, Hercules, CA). Slides were pretreated according to the producer's information. Cells were fixed in 3.7% (wt/vol) paraformaldehyde in PBS containing 2% (wt/ vol) saccharose. Laser scanning microscopy was performed with a Zeiss confocal laser scanning microscope (Carl Zeiss, Oberkochen, Germany) working with the blue line (488 nm wavelength) of an argon laser. Oil immersion plan neofluar lenses were used for confocal epifluorescence and for Nomarski differential interference contrast (DIC).
Indirect immunofluorescence of B-cell differentiation antigens.
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Product formation was linear with time (for at least 2 hours). The values obtained without acceptor glycoprotein or without lactose were below the detection limit and corresponded to the CTP reference.
* ST activity was determined by incorporation of 9-F-NeuAc into the acceptors asialo-a, acid glycoprotein for N-glycosylation and asialomucin for 0-glycosylation, as described in the Materials and Methods.
t Lactose was used as acceptor and CMP-9-AMCA-NeuAc as donor substrate as described in the Materials and Methods. Isomers of sialylated lactose were separated by HPLC.
Indirect immunofluorescence staining of B-cell surface antigens was performed as previously described!' As a second antibody, we used goat antimouse IgG + IgM(Fab)* conjugated to HTC. Samples were measured in a FACScan cytometer (Becton Dickenson, Heidelberg, Germany).
RESULTS
B-Cell Lines Release ST Activity Into Culture Medium
The overall activity of ST found in culture supernatants was measured using CMP-[3H]-NeuAc as donor and asialofetuin as external acceptor according to Bauvois et al. 50 ST activity released by the cells into the buffer during the 1 hour of incubation was sufficient to sialylate asialofetuin to various extents. Conditioned buffer of JOK-l and U266 cells contained more ST activity than that of Nalm-6 and IM-9 cells (data not shown).
To determine the linkage specificity of the low ST activities found in culture supernatants, we performed a newly established fluorometric assay using lactose as acceptor and CMP-9-AMCA-NeuAc as donor ( Table 1) . Isomers of sialylated lactose were subsequently separated by HPLC. All cell lines with the exception of IM-9 showed a propensity for a2, 6 ST. The percentage of a2,6 isomer of the lactose substrate was significantly higher than that of the a2,3 isomer when ST activity of culture supernatants was measured (Table l). IM-9 cells were totally deficient of a2,6 ST activity.
The fluorometric method for determination of ST activity developed previously4* allows us to differentiate the acceptor specificity of ST even at low enzyme activities. We examined whether the ST activity secreted by the cell lines preferentially sialylates N-or 0-linked glycoconjugates (Table 1) . Fluoresceinated NeuAc was incorporated into asialo-a,-acid glycoprotein, a protein with defined N-glycosylation, in larger quantities in comparison to the exclusively O-glycosylated asialomucin. U266 cells showed highest ST activity in culture supernatants. IM-9 cells exclusively synthesized ST with a2,3 linkage specificity and exhibited incorporation GROSS ET AL of labeled NeuAc into asialomucin. Overall, ST activity in the culture supernatant was very low in Nalm-6 and IM-9 cells. Because viability of cells during the assays was greater than 95%. ST activity found in the supernatants did not result from cellular leakage.
Cell Su$ace Glycoconjugates Are Sialylated by Extracellular ST Activity
We next asked whether extracellular activity is able to sialylate cell surface glycoconjugates. This approach afforded a new sensitive method to detect very low activities on cell surfaces. To this end, the cells of the four cell lines were washed three times in PBS and then incubated in the presence of CMP-5-F-Neu. The incubation was stopped at various times and the fluorescent NeuAc incorporated into cell surface molecules of live cells was quantitatively assessed using flow cytometry.
The kinetic experiments showed that all four cell lines were able to sialylate cell surface structures by an endogenous, extracellular ST activity when fluorescent CMP-sialic acid was offered as donor (Fig 1) . The standard assay was performed with CMP-5-F-Neu due to its superior kinetic properties and its high resistance to sialidase." Without prior VCN treatment of the cells, the incorporation rate of 5-FNeu was slow in JOK-1 and IM-9 cells and remained at basal levels in Nalm-6 and U266 cells. However, when cells were treated with VCN before the labeling procedure, a significant increase of the 5-F-Neu incorporation rate was observed. A high increase was found in JOK-1 and U266 cells, in contrast to a markedly slower rate in Nalm-6 and I"9 cells. The kinetics of surface sialylation of JOK-1 and U266 cells after VCN-treatment were almost linear during the 2 hours of incubation. The increased incorporation of 5-F-Neu into surface molecules of JOK-1 and U266 cells after VCN treatment indicates that untreated cells express large amounts of sialylated glycans. The differences in fluorescence intensity with and without VCN treatment were smallest in IM-9 cells. This points to the fact that IM-9 cells express fewer sialylated surface structures than the other cell lines.
Surface labeling with fluorescent NeuAc was a temperature-dependent reaction, because no significant label was incorporated when the cells were kept at 0°C for 2 hours. The enzymatic origin of surface sialylation was confirmed by two approaches. (Fig 2) . For this approach, CMP-9-F-NeuAc was applied in the surface sialylation assay because it can be released by sialidases after enzymatic transfer to the oligosaccharide hai in.^^,^' However, cleavage of 9-F-NeuAc proceeds at reduced rate as compared with parent N~UAC.~~.'' The efficiency of the VCN-mediated cleavage was monitored by complete abrogation of CDw75 and HB-6 expression (see Fig 8) . This result also shows that fluorescently labeled acceptor structures are to a large extent accessible for exogenous sialidase. Sialidase-resistant CMP-5-F-Neu was used for most surface sialylation experiments instead of CMP-9-F-NeuAc to avoid the effects of sialidases possibly present in the assay system.
The protease sensitivity of fluorescently labeled cell surface acceptor structures was assayed as follows. JOK-1 cells were incubated in the presence of CMP-5-F-Neu (25 pmoV L) for 2 hours at 37"C, subsequently washed, and further incubated with 0.25% trypsin in PBS for 10 minutes at 37°C. Surface-bound fluorescence of live cells was reduced by 50%, as determined by flow cytometry. Further support for surface location of acceptor structures was obtained by the quenching effect of an antifluorescein antibody; 5-F-Neu labeled JOK-l cells were incubated together for 5 minutes at 4°C with an mouse antifluorescein MoAb (dilution 120) described to efficiently quench FITC-fluorescence emission. The antibody quenched surface fluorescence by 60% as determined by flow cytometry.
Cell surface sialylation was also shown by confocal laser
scanning microscopy of 5-F-Neu-labeled cells (Fig 3) . As also observed by 00w cytometry, fluorescence intensity was weaker without VCN pretreatment of cells (data not shown).
Fluorescence appeared in dot-like, clustered formations at the cell surface (Fig 3A) . Interestingly, not all cells were stained with equal intensity; some were almost negative or staining intensity was less than the detection limit. In accordance with this result, flow cytometric analysis also showed a wide distribution of 5-F-Neu label intensity in the cell populations ranging from almost negative to strongly positive cells (limit values of mean intensity between 50 and 1,000).
Cell Sugace Sialylation Is Mediated by Ecto-ST
We investigated whether soluble ST found in culture supernatants mediates surface sialylation. Surface sialylation followed a linear course, as outlined above (Fig 1) . In contrast, when conditioned culture supernatant of U266 and JOK-1 cells was taken at several time points and ST activity was determined by applying an external acceptor protein (asialo-a,-acid glycoprotein), fluorescence intensity was increasing. Apparently U266 and JOK-1 cells released increasing amounts of ST during an incubation time of 90 minutes (Fig 4) .
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?E.?. l This observation gave rise to the question of whether intensity of surface sialylation is dependent on the amount of ST activity secreted. To test this, we added conditioned media of various preincubation times to washed, fresh cells and incubated them in the presence of CMP-5-F-Neu for an additional 30 minutes. Conditioned culture supernatant, even after 90 minutes of preincubation, did not enhance surface sialylation compared with unconditioned medium during a reaction time of 30 minutes. The same results were obtained regardless whether JOK-I. U266, or IM-9 cells were applied in this assay. As an example, data for cell line U266, which secreted the highest amounts of ST, are depicted in Table 2 . From these results we conclude that the concentration of ST in the culture medium does not influence the rate of surface sialylation. Obviously, secreted ST activity does not contribute to the sialylation of cell surface acceptors. In further support of this assumption, the addition of exogenous acceptor (asialo-a,-acid glycoprotein or asialofetuin) to either desialylated or untreated JOK-I cells incubated together with CMP-5-F-Neu did not significantly reduce surface sialylation (Table 3) . Surface sialylation is apparently mediated by a surfaceexpressed ecto-ST different from that found in the culture supernatant. The efficiency of endogenous, ecto-ST activity was shown when high amounts of exogenous ST activity JOK-1 with and without VCN pretreatment were incubated in the presence of CMP-5-F-Neu (25 pnol/L) for 2 hours at 8°C. The low incubation temperature was chosen to minimize secretion of ST. Exogenous glycoproteins were added at 1.5 mg/mL to the assay. 5-FNeu-labeled cells were measured by flow cytometry.
were applied to the cells. Exogenous a2,6 ST of rat liver at a concentration of 10 mU/mL induced a twofold increase in surface sialylation (Table 4 ), but only after pretreatment of cells with neuraminidase. Apparently, exogenously added ST is not able to significantly improve the sialylation extent achieved by the endogenous ecto-ST.
The question of whether secreted and ecto-ST have the same characteristics concerning acceptor specificity cannot be answered at the moment. The same donor Km value of approximately 8 pmoVL for CMP-5-F-Neu was determined for the secreted and surface-located enzyme of U266 cells (Fig 5) .
To investigate whether surface-located ST is a ligand for other surface molecules or exists as a membrane-integrated protein, we incubated VCN-treated and untreated JOK-1, U266, and IM-9 cells in acidified RPM1 1640 medium (pH 3) for 5 minutes before the flow cytometric enzyme assay. Cells were washed two times with PBS and incubated with CMP-5-F-Neu for 30 minutes at 37°C. Incubation in acidified medium that has been shown to release receptor-bound ligands from the cell surface5' did not affect incorporation of fluorescent NeuAc. If ST were bound to a surface receptor, one would expect at least a diminished fluorescent intensity by this treatment compared with untreated cells. This result indicates that ecto-ST activity of B lymphocytes is not bound to surface components as a secreted product but rather exists as membrane-integrated enzyme. For the control, we also used IM-9 cells from cultures incubated in the presence of 5% fetal calf serum. In these cells, preincubation in acidified medium resulted in decreased incorporation of 5-F-Neu by about 60% (data not shown). This result further underlines that serum-derived ST may stick to the cell surface during cultivation in fetal calf serum-containing medium.
Sugace Sialylation is Not Mediated by intracellular ST Activity
Hypothetically, desialylated surface proteins may be internalized and sialylation may occur by intracellular ST, followed by the reappearance of labeled sialoglycans at the cell surface. Because we observed a linear, continuous increase in fluorescent label after the addition of CMP-5-F-Neu at 37°C (Fig 1) without an apparent lag-phase, such an internalization process appears to be unlikely. We further investigated surface sialylation after blocking of internalization, and intracellular processing to answers this question unequivocally.
When surface sialylation of VCN-desialylated JOK-1 cells in the presence of CMP-5-F-Neu was performed at 8°C for 3 hours, a continuous increase of surface label was measured in flow cytometry (Fig 6) , albeit to a much lower level than at 37°C (after 2 hours of incubation: mean fluorescence 180 (8°C) compared with mean fluorescence 2070 (37°C); for comparative cytometric measurement, the fluorescence amplification was reduced by 7-fold in relation to data shown in Fig 6) . At the reduced incubation temperature, membrane
For personal use only. on April 1, 2017. by guest www.bloodjournal.org From various concentrations for 45 minutes, followed by VCN treatment before the sialylation assay (60 minutes). No effects of brefeldin A on surface sialylation were observed (Table 5) .
In summary, the blockade of internalization, disruption of TGN structures, and impairment of intracellular processing pathways did not inhibit surface sialylation. From these data, we suggest that surface sialylation of glycans on human B cells under the given experimental conditions is a process mediated by a surface-located ST that does not require intracellular recycling of any of the components involved. traffic is blocked completely. As already observed, at 37"C, sialylation reaction also started without lag phase. Treatment of cells with glutaraldehyde at concentrations of 0.05% for 30 seconds has been shown to block internalizat i~n .~~ When JOK-1 cells fixed with glutaraldehyde at incremental concentrations (from 0.01% to 0.05%), fluorescent label was incorporated during an assay time of 60 minutes at 37°C using CMP-5-F-Neu as substrate. The label obtained was reduced in its intensity as compared with untreated cells (at 0.02% glutaraldehyde, the fluoresecence mean intensity was reduced by 33%; at 0.05% glutaraldehyde, the fluorescence mean intensity was reduced by 52%). The fixation process probably affects activity of surface ST. These results strongly indicate that, under the given experimental conditions, fluorescent label is transferred by a surface-located ST that is affected in its activity by the fixation.
1500->
Because cell surface sialoglycans may passage the lysosomal compartment en route to the Golgi compartment during their recycling pathway,54 we applied the lysosomotropic amine chloroquine to impair functions of this acidic organelle. VCN-desialylated JOK-1 cells treated with chloroquine at various concentrations for 45 minutes were assayed for their capacity to perform surface sialylation. After 60 minutes of incubation in the presence of chloroquine and CMP-5-F-Neu, chloroquine-pretreated cells did not show decreased incorporation of fluorescent label into surface glycans in comparison to untreated cells (Table 5 ).
The fungal lactone brefeldin A is an inhibitor of membrane transport. In particular, it causes disassembly of Golgi structures and also affects the organization of lysosomes, endosomes, and trans-Golgi network (TGN).55. 56 We incubated JOK-1 cells together with brefeldin A at
Antibody-Defined Surface Glycoproteins and Oligosaccharide Structures Are Resialylated by Ecto-ST
To examine whether ecto-ST of B cells is capable to resialylate major cell surface antigens of B lymphocytes, we performed resialylation of VCN-desialylated JOK-1 cells with endogenous ecto-ST using CMP-5-F-Neu as substrate. Thereafter, cells were lysed and various surface antigens were immunoprecipitated from the cell lysates by the respective MoAb. Immunoprecipitates were separated on SDS-PAGE and blotted onto nitrocellulose membranes. Fluorescent label of resialylated antigens was visualized using an anti-FITC antibody coupled to alkaline phosphatase. As can be seen in Fig 7, HLA class I and I1 glycoproteins were major targets for the ecto-ST-mediated sialylation process. The transferrin receptor (CD71) and surface IgM (p-chain) were also resialylated by ecto-ST. These results prove that ecto-ST is able to resialylate major, functionally important surface glycoproteins of B cells. The four cell lines investigated express various a2.6 sialylated carbohydrate structures that are recognized by MoAbs." The expression of some of these epitopes is listed in Table 6 . Recognition of these epitopes can be abolished by treatment of the cells with VCN before antibody staining.
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Interestingly, MoAb 1 B2, which recognizes nonsialylated lacto-N-glycosyl type I1 carbohydrate chains (GalP1-4GlcNAcPI-R)," did not react with surface-exposed epitopes on the four cell lines studied (Table 6 ). Only after desialylation did lB2 epitopes become visible on the cell surface. Consequently, cell line IM-9, which is deficient for a2.6 ST, did not express any of the sialylated epitopes investigated. These results indicate that lB2-related sugar sequences are predominantly surface-expressed in sialylated form.
Most of the sialylated oligosaccharide epitopes (listed in Table 6 ) are expressed by JOK-I cells and to a smaller extent by U266, whereas Nalm-6 carried only a few of these epitopes. N-acetyl-lactosamine core structures became visible after VCN treatment on U266 cells, as shown by staining with MoAb 1B2, indicating that this cell line expresses more a2,6 sialylated oligosaccharide structures. This has recently been verified by using an extended panel of MoAbs directed against a2.6 sialylated sugar sequences.'"
We then addressed the question as to whether ecto-ST activity is able to sialylate these MoAb-defined, surfaceexpressed carbohydrate sequences. For this purpose. JOK-1 cells were desialylated by VCN treatment and incubated in the presence of unlabeled CMP-NeuAc with and without the addition of external a2,6 ST derived from rat liver. Cells were stained with MoAb against CDw75, CDw76. HB-4, HB-6, and the 1B2 epitope. Antibody reactions were measured by flow cytometry. As can be seen in Fig 8, VCN treatment abolished reactivity with those antibodies dependent on a2,6 sialylated carbohydrate epitopes (CDw75, CDw76, and HB6) and increased reaction with MoAb 1 B2, which detects nonsialylated N-acetyl-lactosamine groups. Resialylation with ecto-ST activity let the CDw75 and the HB6 epitopes reappear at the cell surface and, consequently, the 1 B2 epitope diminish in its expression. The CDw76 epitope remained unsialylated by this treatment. Exogenous rat ST only slightly enhanced reappearance of the CDw75 epitope and, more significantly, that of the HB-6 antigen compared with endogenous ecto-ST. Under the experimental conditions described, CDw75 could be resialylated by 1 1% (endogenous ST) and 17% (exogenous ST) and HB-6 by 18% (endogenous ST) and 48% (exogenous ST). When alterations in 1B2 expression, representing N-acetyllactosamine groups, were taken to assess resialylation efficiency, approximately 33% for endogenous and 70% for exogenous ST activity was calculated.
In kinetic experiments, a continuous increase in resialylation of the surface-expressed HB-6 epitope was detected (Fig 9) . Although the time course implied a lag phase of approximately I O minutes that is most likely caused by statistical deviation of low mean fluorescence values, this experiment is in accordance with the linear increase of fluorescent label as shown in Figs 1 and 6 . Incubation without the addition of exogenous CMP-NeuAc did not result in resialylation of HB-6, thus excluding effective sialylation of HB-6 by regular glycoprotein turnover. The same result was obtained with CTP in excess (Fig 9) . Successful resialylation of the CDw7.5 and HB-6 epitopes indicates that the ecto-ST activity of B cells is specific for a2,6 linkage.
Ecto-ST of B Cells Does Not Sialylate Su$ace Glycans of Neighboring Erythrocytes
Because surface-located ST has been discussed to mediate contacts to other cells by sialylating their surface structures,' we investigated whether ecto-ST of B cells is able to sialylate neighboring cells. For this purpose, we incubated JOK-1 cells together with desialylated erythrocytes in the presence of CMP-5-F-Neu for up to 20 hours at 8°C and measured the fluorescent surface label of erythrocytes. Erythrocytes have been reported to express CDw75 and HB-6, those structures that can be resialylated by ecto-ST (Fig S) .'' No significant label was measured when desialylated erythrocytes were incubated alone, because erythrocytes neither express ecto-ST nor secrete ST a~tivity.~' Also, when desialylated erythrocytes were incubated together with JOK-1 cells, no fluorescent label was observed on erythrocytes gated by their specific scatter signals in flow cytometry. Surface sialylation of cocultivated JOK-l cells was not reduced. However, rat liver a2,6 ST is able to transfer fluorescent sialic acid to erythrocyte surface glycans." The failure to transfer label to erythrocytes further speaks against interference by a soluble ST. 
DISCUSSION
We investigated the existence and possible function of surface-located ecto-ST on differently maturated human B cells. The ecto-ST activity was characterized, in particular, with regard to its possible involvement in surface sialylation. Because the B-cell lines studied also released ST activity into the culture medium, secreted ST had to be distinguished from the cell surface ST form.
These B-cell lines primarily secreted ST with specificity for a2,6 linkage and a propensity for N-linked oligosaccharides. This finding is in accordance with intracellular ST activities found in the cell lines (data not shown). Accordingly, most of the sialylated antigens expressed by B cells may contain a2,6 sialylated, N-linked oligosaccharides. Indeed, surface-expressed sialoglycans of B lymphocytes defined by MoAbs were found to be sialylated in a2,6 linkage."
U266 and JOK-1 cells, representing advanced maturation stages, released the highest amounts of ST activity, with preferential affinity for a2,6 N-glycan acceptors followed by the pre-B-cell line Nalmd. In contrast, the myeloma cell line IM-9 is devoid of a2,6 ST and released only trace amounts of ST activity with specificity for a2,3-linked sialic acid.
In a recent study, normal activated B cells were found to express more a2,6 ST transcripts than mature stages of B cells, which points to increased production of a2,6 ST during B-cell a~tivati0n.l~ Although extracellular ST activity has In an earlier report, it was shown by radiometric assays and electron microscopic autoradiography that extracellular ST activity of murine leukemic L1210 cells is able to sialylate cell surface structures." Plasma membrane-located ST was observed on intestinal cells by immunoelectron microscopy.** On B lymphocytes, we and others could not detect surface-expressed ST by means of antibodies directed against a2,6ST.'*.I3 We reasoned that immunostaining may be too insensitive to detect ecto-ST on lymphocytes. As shown here, surface ST of B lymphocytes could only be detected by its enzymatic activity. The enzymatic assay system we used amplifies the fluorescent detection to a great extent, thus resulting in a higher sensitivity compared with fluorescent antibody reactions.
We observed that all cell lines tested incorporated fluorescent sialic acid into cell surface molecules without the addition of exogenous ST activity. The reaction was significantly increased when sialidase-treated cells were used for the assay. Surface sialylation was specific because the incorporation of labeled NeuAc could be inhibited by the addition of unlabeled CMP-NeuAc or CTP and by incubation at 0°C.
Moreover, fluorescein-labeled, sialylated glycoproteins could be visualized in Western blots. The reaction affected surface-expressed molecules because incorporated fluorescein label could be drastically reduced by subsequent VCN treatment of live cells, as shown by flow cytometric analysis. Fifty percent of fluorescently labeled acceptors were sensitive to mild trypsination. The resistant fraction may be, at least in part, composed of glycosphingolipids.* Surface sialylation was not influenced by the soluble ST activity because conditioned media did not significantly enhance sialylation compared with the 30 minutes of incubation with unconditioned medium. This finding strongly pointed to a sialylation mediated by an ecto-ST different to soluble ST. In addition, the kinetics of surface sialylation differed from those of supernatant ST when the external acceptor was applied. Also, ecto-ST seems to be a membrane-integrated enzyme because treatment to release noncovalently attached molecules from the cell surface remained ineffective.
Several observations speak against a sialylation of recycled glycans by intracellular ST. (l) In kinetics of fluorescent label incorporation, no lag-phase was measured. For internalization of surface glycoproteins and subsequent resialylation by intracellular ST, one would expect a distinct lag-phase. (2) When internalization was blocked either by lowered incubation temperature (8°C) or by glutaraldehyde fixation, ST activity was determined, albeit at reduced rates. Because
For personal use only. on April 1, 2017. by guest www.bloodjournal.org From ecto-sialylation is a temperature-dependent process, reduced activity at 8°C was expected. Glutaraldehyde fixation greatly reduces the mobility of surface proteins or affects protein structure, thus influencing the enzymatic activity. (3) Chloroquine and brefeldin A, substances that alter intracellular trafficking, showed no effect on the intensity of surface sialylation when CMP-F-NeuAc was added to these cell cultures.
Also, because CMP-F-NeuAc is a membrane impermeable probe, sialylation of surface glycoporteins with fluorescent substrate must take place outside. In an earlier study, intracellular trafficking of cell surface sialoglycoconjugates has been investigated.60 It was found that the bulk of sialoglycans do not recycle to intracellular organelles with ST activity. Thus, there is ample evidence that surface sialylation as measured here is a result of a surface-located ST. Comparing ecto-ST with exogenously added rat liver ST, an increase in sialylation by exogenous ST was only observed on VCNtreated cells when the exogenous enzyme was applied in high excess. This could mean that either galactose acceptor sites are better accessible to ecto-ST than to exogenous ST from rat liver or that acceptor fine specificity of both enzymes is different.
Cell surface ST was able to resialylate major cell surface glycoproteins of B cells such as HLA class I and 11, the transferrin receptor, and surface IgM. Moreover, surface a2,6 sialoglycan structures CDw75 and HB-6 were resialylated in the presence of CMP-NeuAc. Other antigens of this group, such as CDw76 and HB-4, remained unreactive with the respective MoAb after desialylation. Steric hindrance or structural modifications, such as fucosylation or different branching of the respective oligosaccharides, may impede accessibility of acceptor sites in these molecules. In contrast to resialylation by ecto-ST, terminal glycosylation in the Golgi compartment is mediated by concerted and competitive action of several glycosyltransferases.
On the other hand, selective sialylation may be a result of enzyme tine specificity. The superior resialylation efficiency of distinct surface structures (HB-6 and CDw75) achieved by surface active ST compared with exogenous ST from rat liver is in accordance with the observation published previously that surface ST, although adding back only a small percentage of total surface sialic acid, specifically restored structures involved in mixed lymphocyte reactions.*' Thus, although only present in small numbers, surface ST is able to resialylate distinct surface structures to a great extent. Moreover, the use of carbohydrate-specific antibodies and antibodies against protein structures shows that, although only distinct carbohydrates are resialylated by ecto-ST, most functionally important surface antigens are reached by the enzyme. Because the epitopes recognized by CDw75 and HB-6 require sialic acid in a2,6 position, these experiment provide further proof that ecto-ST of human B cells is an a2,6 ST.
Ltk-cells transfected with the human a2,6 ST gene convert from negative to high expression of CDw75 at the cell surface.'" On these transfectants, only very low levels of surface ST activity could be detected by flow cytometry using fluorescent CMP-NeuAc as the donor substrate. Furthermore, CDw75 could not be reconstituted on VCN-pretreated Ltk-transfectants in the presence of exogenous CMP-NeuAc (unpublished results). These experiments confirm that overexpression of Golgi-located a2,6 ST is not necessarily associated with surface expression of the corresponding ST activity.
A major reservation against a physiologic role of ecto-ST was the question of whether CMP-NeuAc as substrate is available in the extracellular milieu. However, several studies describe the presence of sugar nucleotides in extracellular fluids. CMP-NeuAc was found in human serum"." and evidence for extracellular UDP-Gal accessible to cell surface galactosyltransferase was given." Although concentrations of serum CMP-NeuAc were found to be low, it should be considered that ecto-ST of B cells was efficiently acting at low donor substrate concentrations (Fig 5) .
Ecto-ST may have a physiologic role as an adhesion molecule in cell-cell interactions, as has been shown for the galactosyltransferase.' To examine this possibility, we incubated desialylated erythrocytes together with JOK-I cells and CMP-F-NeuAc. Although erythrocytes express CDw75 and HB-6,'" no fluorescent label was transferred to erythrocytes under these experimental conditions. The surface ST apparently requires very close contact for enzymatic activity that may be only provided by surface glycans on the same cell.
We tentatively conclude that ecto-ST of B cells is not primarily involved in cell to cell interaction. It was recently shown that the CD22 lectin interacts with the CDw75 epitope during B-B-cell adherence.63 Ecto-ST may have a task in a2,6 sialylation of ligand structures on the cell surface, thereby regulating adhesion processes.
